Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " August 01, 2012":" August 31, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Recruiting Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus
Condition: HIV
Interventions: Drug: antiretroviral therapy;   Behavioral: cell phone reminders;   Behavioral: contingency management for adherence
2 Completed Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique
Conditions: Anemia;   Fever;   HIV Positive
Intervention:
3 Completed Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients
Condition: HIV Infection
Intervention: Procedure: colonoscopy with endoscopic biopsies
4 Suspended Pilot Study of Diflunisal in HIV-infected Adults
Condition: HIV Infection
Intervention: Drug: Diflunisal
5 Unknown  HIV Indicator Diseases Across Europe Study
Condition: HIV
Intervention:
6 Completed Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
Condition: HIV Dementia
Intervention: Drug: Ferumoxytol
7 Completed Body Image in Youth With HIV
Conditions: Human Immunodeficiency Virus;   HIV
Intervention: Other: Questionnaire
8 Completed Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study
Conditions: HIV Infection;   Adverse Drug Reaction;   Quality of Life
Intervention: Drug: Raltegravir switch
9 Recruiting Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection
Condition: Human Immunodeficiency Virus
Interventions: Drug: TwHF;   Drug: placebo treatment
10 Completed Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program
Condition: Human Immunodeficiency Virus Infection
Intervention:
11 Completed Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)
Conditions: Human Immunodeficiency Virus;   Immune Reconstitution Inflammatory Syndrome
Interventions: Other: Urgent ART;   Other: Early ART
12 Completed Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
Condition: HIV
Interventions: Drug: Oral FTC/TDF (Daily Emtricitabine/Tenofovir Disoproxil fumarate Tablet);   Drug: Rectal Daily TFV RG 1% gel (Rectally applied Tenofovir Reduced Glycerin 1% Gel);   Drug: Rectal RAI-associated TFV RG 1% gel (Receptive Anal Intercourse Associated rectally applied Tenofovir Reduced Glycerin 1% Gel)
13 Completed ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment
Condition: HIV
Intervention: Other: Tenofovir Dose Adjustment
14 Terminated ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
Conditions: HIV;   Atherosclerosis
Interventions: Drug: niacin/laropiprant;   Drug: Placebo
15 Completed Determination of Optimum Age for DXA Screening for Osteoporosis in HIV - The Probono 1 Study
Conditions: Osteoporosis;   Fractures;   HIV Infection
Intervention:
16 Active, not recruiting An Interactive Game for HIV Prevention in Early Adolescents
Conditions: HIV;   Risk Reduction
Interventions: Behavioral: Experimental Video Game;   Behavioral: Off the Shelf Video Game
17 Unknown  Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection
Condition: AIDS/HIV PROBLEM
Interventions: Drug: RAL+TDF+LPV/r;   Drug: 3TC+TDF+LPV/r
18 Unknown  Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy
Condition: AIDS/HIV PROBLEM
Intervention: Drug: TDF+3TC+EFV
19 Completed Study to Evaluate Safety and Efficacy of UB-421 Antibody in HIV-1 Infected Adults
Condition: HIV-1 Infection in Adults
Intervention: Drug: Antibody UB-421
20 Unknown  HIV Reverse Cholesterol Transport Study
Conditions: HIV;   Dyslipidemia
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.